cervicorn consulting

Proceed To Buy

USD 4750
USD 3800
USD 8750
USD 2100
USD 7500

Minimally Invasive Surgery Market (By Type: Electrosurgical Devices, Imaging & Visualization Systems, Surgical Devices, Medical Robotics, Endoscopy Devices; By Application: Cardiology, Neurology, Gastrointestinal, Cosmetic Surgery, Urological Surgery, Orthopedic, Dental Surgery, Gynecological Surgery, Others; By End-Users: Hospitals & Clinics, Ambulatory Surgical Centers, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Analysis And Forecast 2024 To 2033

Minimally Invasive Surgery Market Size and Growth 2024 to 2033

The global minimally invasive surgery market size was valued at USD 71.94 billion in 2023 and is expected to be worth around USD 271.29 billion by 2033, growing at a compound annual growth rate (CAGR) of 14.19% from 2024 to 2033.

The minimally invasive approach results in less intraoperative blood loss, less postoperative pain, and shorter rehabilitation times, as well as a significant reduction in overall and postoperative postoperative morbidity. Thus, surgery becomes a module of modern multidisciplinary care, fitting into multi-modular treatment options at different times, extending and expanding the options available to patients. In this rapidly changing environment, the requirement to learn and refine not only open surgical but also various minimally invasive techniques at a high level has had a profound impact on modern surgical training pathways. The use of modern e-learning tools and new and hands-on surgical training opportunities has been easily integrated into modern surgical training.

Minimally invasive surgery (MIS) is performed through smaller incisions compared to traditional open surgery, resulting in shorter recovery times and lower risks and complications. There is a growing demand for endoscopic, laparoscopic, or keyhole surgery, and other MIS devices and surgical technologies such as robotic-assisted surgical systems that can help surgeons perform more precise and less invasive procedures.

Minimally Invasive Surgery Market Growth Factors

  • Benefits Associated with MIS: Fewer incisions with high precision, faster recovery, less pain and scarring, and shorter hospital stays are some of the benefits offered by minimally invasive surgeries. Minimally invasive procedures include procedures like laser ablation and radiofrequency (RF) ablation.
  • Increasing Adoption of MIS: Compared to traditional procedures, laparoscopic treatments are less invasive and less expensive when in terms of hospital stays and pre-and post-operative care. Patients who undergo laparoscopic procedures experience less blood loss, recover faster from surgery, and have fewer problems afterward. In addition, medical professionals believe that these surgeries can save hospitals money, making them better than open surgeries.
  • Increased Number of Surgical Procedures: A major part of healthcare is surgical care. In all developed nations, surgical care is now a basic component of the healthcare systems. Consequently, there is a need for these nations to provide equal access to surgical services.
  • Growth Aging Population: People 65 and older make up the fastest-growing demographic in the United States due to the aging of the baby boomer generation. Given that the elderly make up the majority of healthcare service users, the aging population will present new difficulties for the healthcare system.

Increasing Robotic Surgery

  • There is a lot of excitement surrounding the introduction of robotic surgery in minimally invasive surgery. With robotic surgery, a surgeon can mimic a patient's natural hand movements while performing laparoscopic procedures.
  • To overcome these constraints, robotic systems have been incorporated into clinical practice. These systems provide advantages like enhanced dexterity, increased stability, improved movement accuracy, and the capacity to access target anatomies situated in previously inaccessible parts of the body through the use of flexible, customized devices.

Growing Use of Advanced Cameras

Some of the aspects that can be looked into in the future are related to the field of developments in VR, stereoscopic 3D cameras, and augmented reality (AR) cameras. Some research groups have reported the development of AR visualization for laparoscopic cameras.By combining LUS and AR technology in a 3D stereoscopic camera, one can now view the organ undergoing ultrasound and its abnormalities in real-time right on the organ itself and make surgical decisions for accurate dissection with precise movements so that the resection margins are kept minimal but adequate and the surrounding structures are protected.

Technological Advancements

  • The market is constantly changing due to innovative advancements, especially in the areas of cardiac, orthopedic, ophthalmic, neurological, and oral surgery. The consistent technological advancements in this field are offering higher quality instruments that enable surgeons to effectively perform surgical procedures without compromising patient safety. Improved product designs are offering accuracy and a certain level of control in the operating room.
  • Technological advancements in MIS instruments to improve accuracy, portability, and cost-effectiveness are among the factors that are driving market players to constantly improve and launch advanced devices.

MIS for chronic Pancreatitis

  • Chronic pancreatitis is a debilitating inflammatory disease of the pancreas characterized by intractable pain that results in a poor quality of life. Since chronic pancreatitis is a benign condition in which pain is the main indication for intervention, a minimally invasive approach is an attractive proposition.
  • Recent studies have demonstrated the feasibility of laparoscopic and robotic surgery for chronic pancreatitis. In addition, with advances in endoscopic treatment, there is a trend toward less invasive treatment of chronic pancreatitis.

Report Scope

Area of Focus Details
Market Size in 2024 USD 82.15 Billion
Expected Market Size in 2033 USD 271.29 Billion
Growth Rate 2024 to 2033 14.19%
Front-runner Region North America
Fastest Expanding Region Asia-Pacific
Key Segments Type, Application, End User, Region
Key Companies Abbott Laboratories, Arthrex, Asenus Surgical, Conmed, Becton, Dickinson & Company, InMode Ltd., Integrated Endoscopy, Boston Scientific Corporation, Eximis Surgical, GE Healthcare, OmniGuide Holdings Inc., Titan Medical Inc., Johnson & Johnson Medtech, Medtronic plc, NuVasive, Orthofix Holdings,Inc, Smith & Nephew, Stryker corporation, Fractyl Inc., Virtual Ports, Zimmer Biomet holdings, Hoya Corporation

Minimally Invasive Surgery Market Dynamics

Drivers

Increased Cases of Chronic Diseases

  • Long-term illnesses, known as chronic diseases, are often incurable but sometimes treatable and controllable. As people become more aware of this problem, there is an increasing need for minimally invasive surgical tools. Less scarring, less post-operative discomfort, shorter hospital stays, faster recovery times, and less stress on the immune system are all common outcomes for patients who undergo this type of surgery.
  • In 2021, the World Health Organization (WHO) reported that millions of deaths worldwide were due to chronic diseases. The death cases for each disease are as follows cancer (1.5 million cases), diabetes (4.1 million cases), respiratory disorders (9.3 million cases), and cardiovascular diseases (17.9 million cases). Approximately 41 million deaths yearly, or 71% of all deaths globally, are caused by chronic illnesses.

Growing Prevalence of Orthopedic Diseases

  • The field of orthopedic surgery is going through a significant transition phase. The number of procedures that are carried out in ambulatory surgery centers (ASCs) has increased drastically owing to the growing need for treatments like spine surgery and joint replacements because of the rapidly aging population. The ASCs due to their efficiency and cost-effectiveness are becoming one of the popular choices for minimally invasive procedures.
  • In July 2022, the World Health Organization (WHO) estimated that ~1.71 billion people worldwide suffered from musculoskeletal disorders.

Restraints

High Costs

  • In comparison to various minimally invasive procedures, robot-assisted surgeries are very expensive, which causes treatment delays or avoidance. In several European countries hospital budgets have been cut, and more such things are anticipated in the future. Due to budgetary restrictions cost containment strategies are becoming more and more important in many areas of hospital operations.

Complications Associated with MIS

  • Even with the many advantages provided by minimally invasive surgical procedures, complications are still a possibility, though not as much as with open surgery. Also, sometimes healthcare professionals are reluctant to employ MIS techniques, due to patient safety concerns, and the possibility of organ damage, bleeding, or infection during these treatments.

Opportunities

Expansion into Emerging Markets

  • The minimally invasive surgery market has substantial growth prospects in emerging markets owing to the continuous development of the regions. Further, the rising demand for healthcare and proper infrastructure is opening up new opportunities for market expansion.
  • Furthermore, it is also expected that the rising healthcare costs, growing patient population, and rising disposable income will all support market expansion in the future.

Rising Investment in Healthcare Infrastructure

  • Health infrastructure is an important indicator for understanding the healthcare provisions and mechanisms in a country. It also indicates the investment and priorities given to infrastructure development. Therefore, focusing on health infrastructure is very important for urban planning and development.
  • A plan that sets agreed investment priorities for health infrastructure will help align resource allocation with needs. This plan should be nationally owned, include private sector input, and be embedded in the overall national plan for the health sector as well as national and local development strategies.

Challenges

High Market Consolidation

  • The minimally invasive surgery market is highly consolidated. Only key companies can afford high capital investments as well as the high cost of research & development and manufacturing. It will prevent new entrants from entering the minimally invasive surgery market which is a challenge for the new entrants.

Skilled Labor Shortages

  • The lack of skilled healthcare professionals in the industry is one of the significant challenges that the minimally invasive surgery market faces. Specialized skill sets are required for handling the equipment during any surgery and the lack of qualified professionals can lead therefore to delays, increased costs, and compromised quality of work.

Minimally Invasive Surgery Market Segmental Analysis

Product Analysis

Based on product, the global market is segmented into electrosurgical devices, imaging & visualization systems, surgical devices, medical robots, endoscopy devices and others. The surgical devices segment has dominated the market in 2023 with highest revenue share.

Electrosurgical Devices: A surgical technique used for controlling bleeding and quickly dissecting soft tissues is known as electrosurgery. Heat is generated by the electrical resistance of these soft tissues to an electromagnetic current. The waveform, power used and surgical technique help decide the endpoints in the surgery. In both open and minimally invasive surgery electrosurgery is the most commonly used form of surgical energy. An electrosurgical device comprises a generator and a handpiece with one or more electrodes. A switch on the hand piece or a foot switch is the controller of the device. Electrosurgical generators can generate various electrical waveforms and depending upon these waveforms, the corresponding effects on the tissues also change. Further, advanced electrosurgical devices have revolutionized laparoscopic surgery and led to increasing acceptance of more complex procedures.

Imaging & Visualization Systems: The rise of chronic diseases and less invasive surgical procedures often requires imaging systems to visualize the affected area. In addition, these innovations provide surgeons with improved clarity and precision in observing the surgical site, resulting in less tissue trauma, shorter operative times, faster patient recovery, and improved overall outcomes.

Surgical Devices: Surgical devices are classified into handheld instruments, laparoscopy devices, guiding devices, and inflation systems, all of which play an important role in minimally invasive surgery (MIS) and significantly improve surgical outcomes through their continuous development and innovation. Technological advances in surgical devices are a major driver of the market as the advanced devices aim to improve the precision, flexibility, and safety of the process, ultimately benefiting patients.

Medical Robotics: Medical robots are used in various surgeries, a form of minimally invasive surgery. The medical robots are used in a surgical platform with the surgical instruments attached to the mechanized "arms" and are controlled by a surgeon at the console. Robotic surgery has experienced exponential growth and proliferation over the past decade. Today, most prostate removal surgeries are performed robotically. In addition, there has been tremendous growth in robotic surgical applications for kidney, bladder, and reconstructive surgical procedures.

Endoscopy Devices: An endoscope is a medical device with a light attached. It is used to look inside a body cavity or organ. The endoscope is inserted through a natural opening, such as through the mouth during a bronchoscopy or through the rectum during a sigmoidoscopy. A medical procedure that involves the use of an endoscope of any kind is called an endoscopy. Several endoscopic devices are currently FDA-approved for use in endoluminal tissue apposition. These devices are currently being used with varying degrees of success to reduce the size of a gastric bypass pouch or gastrojejunostomy.

Application Analysis

Based on application, the global market is segmented into cardiology, neurology, gastrointestinal, orthopedic, dental, gynecological and others. In 2023, the neurology segment was leading in the market.

Cardiology: Technological advancements, particularly in precise surgical instruments and imaging techniques, have accompanied the adoption of minimally invasive surgery (MIS) in cardiothoracic procedures. With increased proficiency in MIS techniques, medical professionals are demonstrating increased assurance when utilizing these methods in intricate cardiothoracic procedures. The adoption of MIS in cardiothoracic surgery is also being aided by changing healthcare reimbursement frameworks and policies that support efficient and economical care pathways.

Neurology: Several factors are driving the increasing use of minimally invasive surgery (MIS) in neurological treatments. Technological advances have improved the precision of minimally invasive procedures, particularly in imaging techniques and surgical instruments. There is also a strong incentive to reduce postoperative complications, decrease patient morbidity, and shorten recovery times, all of which are benefits of MIS in neurological surgery.

Gastrointestinal: Gastrointestinal and minimally invasive surgery focuses on diagnosing and treating patients with diseases of the gastrointestinal tract. These problems can include both chronic and acute conditions. Minimally invasive surgery can reduce damage to human tissue and is often robot-assisted surgery. Minimally invasive gastrointestinal surgery typically uses a high-resolution video camera to project the surgical field onto a screen in the operating room.

Orthopedic: The orthopedic segment growth is being driven by the rising prevalence of various orthopedic conditions, including carpal tunnel syndrome and osteoarthritis. Numerous orthopedic surgical procedures, such as microscopic treatment of complex musculoskeletal conditions, arthroscopic repairs of sports injuries, and total joint replacements, have been made better owing to new research and technological advancements. Minimally invasive surgery is incorporated into the field of orthopedics by making a large, open incision exposing the entire joint and then using smaller and more focused incisions to treat the specific problem areas. This surgery in turn provides patients with a shorter recovery period, less pain post-surgery, and reduced risk.

Dental: Micro dentistry, another name for minimally invasive dentistry, is a term used to describe a variety of procedures all done with the primary objective of preserving and enhancing the patient's oral health and providing healthy tooth structure. While solving any form of dental issue minimally invasive dentistry aims towards removing as little of the tooth structure as possible thus enhancing the patient's overall oral health.

Gynecological: Minimally invasive gynecological surgery specializes in examining and treating people with a variety of noncancerous (benign) gynecological conditions, such as heavy menstrual bleeding (menorrhagia), pelvic pain, endometriosis, irregular menstrual bleeding (metrorrhagia), and ovarian cysts. Minimally invasive gynecological surgery uses less invasive techniques such as laparoscopy or hysteroscopy to surgically treat gynecological conditions.

Others: The other segments include urological, cosmetic, and vascular. Minimally invasive urological surgery treats urological diseases in a way that causes less damage to your body and carries fewer risks than open surgery. Urologists can use minimally invasive surgery to correct problems affecting your urinary system as well as your female and male reproductive systems. Minimally invasive cosmetic procedures are small, noninvasive surgical treatments that are designed to slightly enhance or alter your face and body. Minimally invasive cosmetic procedures are a perfect option for all the people who cannot undergo cosmetic surgery due to certain reasons or simply cannot afford the high cost of it. The recent and ongoing developments in radiotherapy, gene therapy, imaging technologies, materials, and devices as well as the techniques to implement them have expanded the treatment options for peripheral vascular diseases.

End-Users Analysis

Based on end user, the global market is segmented into hospitals & clinics and ambulatory surgical centers (ASCs) and others.

Hospitals & Clinics: The increase in chronic diseases among the elderly has led to an increase in hospital admissions for the treatment of chronic conditions. In addition, the expansion of operating rooms, favorable reimbursement policies, the increasing availability of high-tech minimally invasive surgical equipment, and the ability of hospitals to perform a variety of minimally invasive surgeries are attracting patients.

Ambulatory Surgical Centers (ASCs): With the introduction of higher-quality health insurance plans and tighter networks, people are becoming more conscious of costs in their medical decisions. Although the opportunity for cost savings varies by program and surgery, research has consistently shown lower prices in outpatient clinics, providing significant incentives for patients to change their treatment location. The growing patient base, quick adoption of the newest technology for minimally invasive procedures, high preference for outpatient surgical services due to their low outpatient service costs, and improvements in ambulatory care settings are expected to drive the segment growth.

Minimally Invasive Surgery Market Regional Analysis

Based on geography, the global market is segmented into North America, Asia-Pacific, Europe, Latin America, Middle East and Africa. North America region has dominated the market with highest revenue share in 2023.

What factors contribute to North America's dominance in the minimally invasive surgery market

The North America minimally invasive surgery market size was estimated at USD 25.68 billion in 2023 and is expected to reach around USD 96.85 billion by 2033. The North America region is driven by the increasing prevalence of chronic diseases related to lifestyle, and minimally invasive procedures are becoming increasingly popular as compared to more invasive procedures. The growing population and the number of surgeries performed as a result are two factors contributing to the increasing demand for surgical instruments. In addition, chronic diseases like cancer, cardiovascular diseases, and neurological conditions are also very common in the region which is further expected to boost market growth.

Why is Asia-Pacific hit rapid growth in minimally invasive surgery market?

The Asia-Pacific minimally invasive surgery market size was accounted for USD 17.19 billion in 2023 and is predicted to surpass around USD 64.84 billion by 2033. The Asia-Pacific market is expected to grow as more people are opting for cosmetic surgeries, the population is growing, the number of accidents is increasing, and chronic diseases are becoming more prevalent. According to the World Economic Forum, India and China are the two most populated countries and hence have the largest number of patients. The minimally invasive surgery market in China held the biggest market share, while the market in India grew at the fastest rate in the Asia Pacific region.

Europe Minimally Invasive Surgery Market Trends

The Europe minimally invasive surgery market size was valued at USD 19.71 billion in 2023 and is projected to hit around USD 74.33 billion by 2033. The increasing aging population susceptible to chronic diseases, the rise in surgical procedures, and the growing awareness of available treatment options are some of the factors driving the market in Europe. Moreover, rising overall surgery rates may be linked to the prevalence of chronic illnesses. In addition, the UK market for minimally invasive surgery devices was growing at the fastest rate in the European Union, while the German market had the biggest market share.

LAMEA Minimally Invasive Surgery Market Trends

The LAMEA minimally invasive surgery market was valued at USD 9.35 billion in 2023 and is anticipated to reach around USD 35.27 billion by 2033. The LAMEA region's hospital centers are seeing an increase in the use of minimally invasive surgery (MIS). The steady rise in popularity of MIS can be attributed to technological advancements. There has been a bit of a boom in robotic surgery in LAMEA recently, although it has taken some time to become widely accepted there. Due to its many benefits, robotic surgery has been more popular in LAMEA and other markets. The market for minimally invasive surgery is anticipated to benefit from an increase in the release of novel products and the creation of remote-controlled surgical systems.

Minimally Invasive Surgery Market Top Companies

  • Abbott Laboratories
  • Arthrex
  • Asenus Surgical
  • Conmed
  • Becton, Dickinson & Company
  • InMode Ltd.
  • Integrated Endoscopy
  • Boston Scientific Corporation
  • Eximis Surgical
  • GE Healthcare
  • OmniGuide Holdings Inc.
  • Titan Medical Inc.
  • Johnson & Johnson Medtech
  • Medtronic plc
  • NuVasive
  • Orthofix Holdings,Inc
  • Smith & Nephew
  • Stryker corporation
  • Fractyl Inc.
  • Virtual Ports
  • Zimmer Biomet holdings
  • Hoya Corporation

Maintaining an advantage over rivals and guaranteeing dependability, efficacy, and security, provides an edge to the leading companies in the market that are incessantly enhancing their technological capabilities. In February 2023, Vicarious Surgical Inc. and Encision Inc. signed a proof-of-concept service agreement, wherein the surgical robot designed by Vicarious is expected to enhance the accuracy, control, and visualization of the instruments during robotic-assisted minimally invasive surgery. Also, in November 2022, New View Surgical, Inc. announced the closing of the US$12.1 million series to fund the commercialization of the VisionPort system. The key players are highlighting their leadership and influence in the evolving minimally invasive surgery market with their innovative approaches and strategic initiatives.

CEO Statements

Mark Toland, CEO of Medical Microinstruments:

"Against a backdrop of plateauing investments in medical robotics, this support builds on our confidence in a new, less invasive solution for open surgery, a significant market that can benefit from the smallest wristed microinstruments."

Dr Maria Leiloglou, Co-Founder and CEO of EnAcuity:

"Surgeons have difficulty detecting some pathologies such as cancer and surgical structures of interest such as vessels and nerves, partly because the human eye is not sensitive enough to pick up on the subtle color differences that distinguish them. By providing more information, our solution could mark a significant advancement in the field of minimally invasive surgery."

Recent Developments

Key players in the minimally invasive surgery industry are pivotal in delivering a variety of innovative construction solutions, such as prefabrication techniques, sustainable materials, and advanced digital technologies. Some notable developments in the minimally invasive surgery sector include:

  • In January 2024, Arthrex recently launched TheNanoExperience.com, a new patient-focused resource showcasing the science and benefits of nano-arthroscopy. This innovative orthopedic procedure is minimally invasive and has the potential to enable a rapid return to activity with reduced pain.
  • In November 2023, Medtronic announced FDA approval of a minimally invasive device to treat hypertension.
  • In January 2023, PENTAX Medical received CE certification for its PENTAX Medical INSPIRA, a new premium video processor, and the i20c video endoscope series. The new video processor remains compatible with PENTAX Medical's latest endoscope models and sets a new standard with the new i20c video endoscope generation.

These advancements mark a notable expansion in the minimally invasive surgery market, driven by strategic acquisitions and innovative projects. The focus is on boosting sustainability, enhancing construction efficiency, and broadening product offerings to meet diverse building needs.

Market Segmentation

By Type

  • Electrosurgical Devices
    • Electrosurgical generators & accessories
    • Electrocautery devices
  • Imaging & Visualization Systems
    • Ultrasound
    • CT imaging
    • MRI imaging
    • X-Ray imaging
    • Visualization systems
  • Surgical Devices
    • Handheld Instruments
      • Tubular Retractor
      • Suturing Instruments
      • Dilator
      • Probes
      • Laser fiber devices
    • Guiding Devices
      • Guiding catheters
      • Guidewires
    • Inflation System
      • Balloon Catheters
      • Balloon inflation system
    • Laparoscopy Devices
      • Trocar and Cannula
      • Laparoscope
      • RASP (Robotic- Assisted Simple Prostatectomy)
      • Graspers and Dissectors
  • Medical Robotics
    • Robotic Systems
    • Robotic Instruments
    • Robotic softwares & Services
  • Endoscopy Devices
    • Rigid endoscopes
    • Flexible endoscopes
    • Diagnostic endoscopes

By Application

  • Cardiology Surgery
  • Neurology Surgery
  • Gastrointestinal Surgery
  • Cosmetic Surgery
  • Urological Surgery
  • Orthopedic Surgery
  • Dental Surgery
  • Gynecological Surgery
  • Others

By End-Users

  • Hospitals & Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Others

By Region

  • North America
  • Europe
  • APAC
  • LAMEA
...
...

FAQ's

The global minimally invasive surgery market size was estimated at USD 71.94 billion in 2023 and is projected to reach around USD 271.29 billion by 2033.

The global minimally invasive surgery market is poised to grow at a compound annual growth rate (CAGR) of 14.19% from 2024 to 2033.

The driving factors of minimally invasive surgery market are increased cases of chronic diseases, growing prevalence of orthopedic diseases, and growth aging population.

The key players driving minimally invasive surgery market are Abbott Laboratories, Arthrex, Asenus Surgical, Conmed, Becton, Dickinson & Company, InMode Ltd., Integrated Endoscopy, Boston Scientific Corporation, Eximis Surgical, GE Healthcare, OmniGuide Holdings Inc., Titan Medical Inc., Johnson & Johnson Medtech, Medtronic plc, NuVasive and others.

North America is leading region for minimally invasive surgery market and accounted revenue share of 35.70% in 2023.